Cyclandelate

Cyclandelate
Clinical data
AHFS/Drugs.com	Micromedex Detailed Consumer Information
ATC code	C04AX01 (WHO) ;
Identifiers
	IUPAC name 3,3,5-trimethylcyclohexyl hydroxy(phenyl)acetate;
CAS Number	456-59-7;
PubChem CID	2893;
DrugBank	DB04838 ;
ChemSpider	2790 ;
UNII	4139O1OAY2;
KEGG	D00286 ;
ChEBI	CHEBI:3988 ;
ChEMBL	ChEMBL1480987;
CompTox Dashboard (EPA)	DTXSID4022862 ;
ECHA InfoCard	100.006.611
Chemical and physical data
Formula	C17H24O3
Molar mass	276.376 g·mol−1
3D model (JSmol)	Interactive image;
Melting point	55 to 56.5 °C (131.0 to 133.7 °F)
Boiling point	192 to 194 °C (378 to 381 °F) (14 mmHg)
	SMILES O=C(OC1CC(CC(C1)(C)C)C)C(O)c2ccccc2;
	InChI InChI=1S/C17H24O3/c1-12-9-14(11-17(2,3)10-12)20-16(19)15(18)13-7-5-4-6-8-13/h4-8,12,14-15,18H,9-11H2,1-3H3 ; Key:WZHCOOQXZCIUNC-UHFFFAOYSA-N ;
	(verify)

Cyclandelate is a vasodilator used in the treatment of claudication, arteriosclerosis and Raynaud's disease.^[1] It is also used to treat nighttime leg cramps, and has been investigated for its effect against migraine. It is orally administered.

References

^ Smith AL (January 1965). "Cyclandelate (Cyclospasmol) in the Treatment of Peripheral Circulatory Diseases". Angiology. 16: 1–7. doi:10.1177/000331976501600101. PMID 14258038.

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.